A Prospective Analysis of Plasma Phospholipid Fatty Acids and Breast Cancer Risk in 2 Provinces in Canada
- PMID: 33889794
- PMCID: PMC8049855
- DOI: 10.1093/cdn/nzab022
A Prospective Analysis of Plasma Phospholipid Fatty Acids and Breast Cancer Risk in 2 Provinces in Canada
Abstract
Background: Studies suggest that fatty acid status influences breast cancer etiology, yet the roles of individual fatty acids in breast cancer risk are unclear, specifically when central adiposity and menopausal status are considered.
Objectives: This study examined the associations of fatty acid status with breast cancer risk including location, menopausal status, and waist-to-hip ratio as key variables.
Methods: Prediagnostic plasma phospholipid fatty acids were measured in women with breast cancer (n = 393) and age-matched controls (n = 786) from a nested case-control prospective study within Alberta's Tomorrow Project (ATP) and British Columbia Generations Project (BCGP) cohorts. Binary logistic regression models were used to evaluate associations of fatty acids and breast cancer risk with subgroup analysis for menopausal status and waist-to-hip ratio.
Results: Women from BCGP had a higher n-3 (ɷ-3) fatty acid status compared with the ATP (6.4% ± 0.08% vs. 5.3% ± 0.06%; P < 0.001), so subsequent analysis was blocked by cohort. Overall, fatty acids had inconsistent associations with risk. In the ATP among premenopausal women, total long-chain n-3 fatty acids (ORQ4vsQ1 = 1.78; 95% CI: 0.58, 5.43; P-trend = 0.007, P-interaction = 0.07) were positively associated with breast cancer risk, whereas in BCGP, DHA (ORQ4vsQ1 = 0.66; 95% CI: 0.28, 1.53; P-trend = 0.03, P-interaction = 0.05) and total long-chain n-3 fatty acids (ORQ4vsQ1 = 0.66; 95% CI: 0.28, 1.54; P-trend = 0.03) were associated with decreased cancer risk when the waist-to-hip ratio was <0.85.
Conclusions: Our findings suggest that regional variations in fatty acid status influence breast cancer risk, resulting in positive associations of total long-chain n-3 fatty acids in premenopausal ATP women and negative associations of these fatty acids in BCGP women with a waist-to-hip ratio below guidelines. This study highlights the complexity and difficulty in using fatty acid status to predict breast cancer risk in diverse populations without the consideration of other risk factors.
Keywords: ATP; BCGP; biomarkers; breast cancer; fatty acids; risk.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Figures
Similar articles
-
Erythrocyte membrane fatty acids and breast cancer risk: a prospective analysis in the nurses' health study II.Int J Cancer. 2018 Mar 15;142(6):1116-1129. doi: 10.1002/ijc.31133. Epub 2017 Nov 10. Int J Cancer. 2018. PMID: 29071721 Free PMC article.
-
Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers.Cancer Causes Control. 2009 May;20(4):497-504. doi: 10.1007/s10552-009-9314-2. Epub 2009 Mar 3. Cancer Causes Control. 2009. PMID: 19255861 Free PMC article.
-
Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk.Cancer Causes Control. 2016 Jun;27(6):759-73. doi: 10.1007/s10552-016-0753-2. Epub 2016 May 4. Cancer Causes Control. 2016. PMID: 27146840
-
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.Oncologist. 2017 Dec;22(12):1431-1443. doi: 10.1634/theoncologist.2017-0148. Epub 2017 Sep 14. Oncologist. 2017. PMID: 28912152 Free PMC article.
-
A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study.Ann Oncol. 2017 Nov 1;28(11):2836-2842. doi: 10.1093/annonc/mdx482. Ann Oncol. 2017. PMID: 28950350
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
-
- MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, Lim YW, Traina SB, Hilton L, Garland Ret al. . Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295(4):403–15. - PubMed
-
- Goodstine SL, Zheng T, Holford TR, Ward BA, Carter D, Owens PH, Mayne ST. Dietary (n-3)/(n-6) fatty acid ratio: possible relationship to premenopausal but not postmenopausal breast cancer risk in U.S. women. J Nutr. 2003;133(5):1409–14. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources